{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:49:44Z","timestamp":1792158584724,"version":"4.4.0"},"reference-count":5,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/ajhp\/zxag312","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:24:02Z","timestamp":1790583842000},"source":"Crossref","is-referenced-by-count":0,"title":["Structured health-system response to IARC classification of hydrochlorothiazide"],"prefix":"10.1093","author":[{"given":"Esteban","family":"Zavaleta-Monestel","sequence":"first","affiliation":[{"name":"Health Research Department Hospital Cl\u00ednica B\u00edblica \u00a0 San Jos\u00e9 ,","place":["Costa Rica"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeaustin","family":"Mora-Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Health Research Department Hospital Cl\u00ednica B\u00edblica \u00a0 San Jos\u00e9 ,","place":["Costa Rica"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Arguedas-Chac\u00f3n","sequence":"additional","affiliation":[{"name":"Health Research Department Hospital Cl\u00ednica B\u00edblica \u00a0 San Jos\u00e9 ,","place":["Costa Rica"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"issue":"1","key":"2026101609020834800_zxag312-B1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1470-2045(24)00685-5","article-title":"Carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus","volume":"26","author":"Cogliano","year":"2025","journal-title":"Lancet Oncol"},{"issue":"4","key":"2026101609020834800_zxag312-B2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.jaad.2017.11.042","article-title":"Hydrochlorothiazide use and risk of nonmelanoma skin cancer: a nationwide case-control study from Denmark","volume":"78","author":"Pedersen","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"2026101609020834800_zxag312-B3","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/joim.12629","article-title":"Hydrochlorothiazide use is strongly associated with risk of lip cancer","volume":"282","author":"Potteg\u00e5rd","year":"2017","journal-title":"J Intern Med"},{"key":"2026101609020834800_zxag312-B4","author":"European Medicines Agency"},{"key":"2026101609020834800_zxag312-B5","author":"Food and Drug Administration"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag312\/71431423\/zxag312.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag312\/71431423\/zxag312.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:02:11Z","timestamp":1792155731000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article\/doi\/10.1093\/ajhp\/zxag312\/8840841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":5,"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxag312","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"zxag312"}}